| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Profit before tax | -1.0 | -0.1 |
| Net income | -1.0 | -0.4 |
| EPS (diluted, $ a share) | $-0.60 | $-0.36 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
10-Q filed with the SEC, NASDAQ: ADVB. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Advanced Biomed Inc.: key numbers
- Share price
- $2.22Close, Nov 16
- Market cap
- $3.67M
- Shares outstanding
- 1.65MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Services-Medical LaboratoriesSIC 8071
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Advanced Biomed Inc.
All →Advanced Biomed FY 2026 Results: Turns Profitable, Net Income $6.68M
Advanced Biomed Inc. reported a net income of $6.68 million for fiscal 2026, a significant turnaround from a $3.26 million loss in 2025, primarily driven by a $14.02 million gain on the disposal of its biotechnology subsidiaries. The company has pivoted to AI and financial algorithmic software, generating its first $127,637 in revenue from these operations while managing a $6.26 million loss from continuing operations due to high stock-based compensation and credit loss provisions.
- Key figure
- Net income $6.68M